170 related articles for article (PubMed ID: 26343256)
1. The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder.
Uckun Z; Baskak B; Ozel-Kizil ET; Ozdemir H; Devrimci Ozguven H; Suzen HS
J Clin Pharm Ther; 2015 Dec; 40(6):672-9. PubMed ID: 26343256
[TBL] [Abstract][Full Text] [Related]
2. Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients.
de Vos A; van der Weide J; Loovers HM
Pharmacogenomics J; 2011 Oct; 11(5):359-67. PubMed ID: 20531370
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Tsai MH; Lin KM; Hsiao MC; Shen WW; Lu ML; Tang HS; Fang CK; Wu CS; Lu SC; Liu SC; Chen CY; Liu YL
Pharmacogenomics; 2010 Apr; 11(4):537-46. PubMed ID: 20350136
[TBL] [Abstract][Full Text] [Related]
4. Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder.
Zastrozhin MS; Skryabin VY; Petukhov AE; Torrado MV; Pankratenko EP; Zastrozhina AK; Grishina EA; Ryzhikova KA; Shipitsyn VV; Bryun EA; Sychev DA
Pharmacogenomics J; 2021 Aug; 21(4):435-439. PubMed ID: 33608663
[TBL] [Abstract][Full Text] [Related]
5. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.
Yuce-Artun N; Baskak B; Ozel-Kizil ET; Ozdemir H; Uckun Z; Devrimci-Ozguven H; Suzen HS
Int J Clin Pharm; 2016 Apr; 38(2):388-94. PubMed ID: 26830411
[TBL] [Abstract][Full Text] [Related]
6. Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.
Yin OQ; Wing YK; Cheung Y; Wang ZJ; Lam SL; Chiu HF; Chow MS
J Clin Psychopharmacol; 2006 Aug; 26(4):367-72. PubMed ID: 16855453
[TBL] [Abstract][Full Text] [Related]
7. Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay.
Chen B; Xu Y; Jiang T; Feng R; Sun J; Zhang W; Yang W; Li J; Adeniyi O; Chen H
J Clin Pharm Ther; 2013 Dec; 38(6):504-11. PubMed ID: 23981149
[TBL] [Abstract][Full Text] [Related]
8. Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.
de Mendonça Lima CA; Baumann P; Brawand-Amey M; Brogli C; Jacquet S; Cochard N; Powell-Golay K; Eap CB
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):952-6. PubMed ID: 16006029
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.
Reis M; Olsson G; Carlsson B; Lundmark J; Dahl ML; Wålinder J; Ahlner J; Bengtsson F
J Clin Psychopharmacol; 2002 Aug; 22(4):406-13. PubMed ID: 12172341
[TBL] [Abstract][Full Text] [Related]
10. Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression.
Tsuchimine S; Ochi S; Tajiri M; Suzuki Y; Sugawara N; Inoue Y; Yasui-Furukori N
Ther Drug Monit; 2018 Jun; 40(3):356-361. PubMed ID: 29570504
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.
Reis M; Lundmark J; Bengtsson F
Ther Drug Monit; 2003 Apr; 25(2):183-91. PubMed ID: 12657912
[TBL] [Abstract][Full Text] [Related]
12. CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP.
Huezo-Diaz P; Perroud N; Spencer EP; Smith R; Sim S; Virding S; Uher R; Gunasinghe C; Gray J; Campbell D; Hauser J; Maier W; Marusic A; Rietschel M; Perez J; Giovannini C; Mors O; Mendlewicz J; McGuffin P; Farmer AE; Ingelman-Sundberg M; Craig IW; Aitchison KJ
J Psychopharmacol; 2012 Mar; 26(3):398-407. PubMed ID: 21926427
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
[TBL] [Abstract][Full Text] [Related]
14. Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram.
Le Bloc'h Y; Woggon B; Weissenrieder H; Brawand-Amey M; Spagnoli J; Eap CB; Baumann P
Ther Drug Monit; 2003 Oct; 25(5):600-8. PubMed ID: 14508384
[TBL] [Abstract][Full Text] [Related]
15. Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.
Baumann P; Bertschy G; Ramseier F; Nil R
Ther Drug Monit; 2021 Jun; 43(3):436-442. PubMed ID: 33060488
[TBL] [Abstract][Full Text] [Related]
16. CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions.
Kuo HW; Liu SC; Tsou HH; Liu SW; Lin KM; Lu SC; Hsiao MC; Hsiao CF; Liu CY; Chen CH; Lu ML; Shen WW; Tang HS; Liu SI; Chang LH; Wu HY; Chang YS; Yeh TK; Chen ACh; Liu YL
Pharmacogenomics; 2013 Jul; 14(10):1191-201. PubMed ID: 23859573
[TBL] [Abstract][Full Text] [Related]
17. Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.
Ji Y; Schaid DJ; Desta Z; Kubo M; Batzler AJ; Snyder K; Mushiroda T; Kamatani N; Ogburn E; Hall-Flavin D; Flockhart D; Nakamura Y; Mrazek DA; Weinshilboum RM
Br J Clin Pharmacol; 2014 Aug; 78(2):373-83. PubMed ID: 24528284
[TBL] [Abstract][Full Text] [Related]
18. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Lee SH; Newhouse S; Patel H; O'Donovan M; Lewis G; Jenkins G; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Schruers K; Biernacka JM; Uher R; Lewis CM
Eur Neuropsychopharmacol; 2018 Aug; 28(8):945-954. PubMed ID: 30135031
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
Nikisch G; Mathé AA; Czernik A; Eap CB; Jiménez-Vasquez P; Brawand-Amey M; Baumann P
J Clin Psychopharmacol; 2004 Jun; 24(3):283-90. PubMed ID: 15118482
[TBL] [Abstract][Full Text] [Related]
20. Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.
Nikisch G; Eap CB; Baumann P
Pharmacol Res; 2008; 58(5-6):344-7. PubMed ID: 18940259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
